Mesothelioma Prognosis

Written by Karen Selby, RN | Edited by Amy Edel | Last Update: March 13, 2026 | 24 Min Read

Mesothelioma prognosis is a doctor's formal assessment of a likely outcome. Prognosis considers U.S. patient data of typical treatment responses and cancer progression, as well as someone's personal health. Your cancer type, stage at diagnosis, cell type and treatment all shape your prognosis.

Free Mesothelioma Guide

Expert Verified

Written by:

Karen Selby, RN

Edited by:

Amy Edel

Last Update:

March 13, 2026, 24 Min Read

At A Glance

People with mesothelioma who live 5 years or longer: ~15%
Reported being in remission or cancer-free in a 2025 patient survey: 11%
Typical survival after diagnosis with treatment: 12 to 24 months
5-year survival rate for peritoneal mesothelioma with surgery and HIPEC: 47% to 52%
Life expectancy without treatment: 6 to 8 months

Expert & Survivor Perspectives

“The prognosis for mesothelioma patients is not as good as it is with some other cancers… But it is not nearly as bad as it is often portrayed. And so what I try to convey to patients is a lot of this is based on all [patients]. And many patients with mesothelioma… are diagnosed very late in the game. …Factors that contribute to that prognosis are very individual.”

Andrea Wolf,
Thoracic Surgeon, Director of the New York Mesothelioma Program at Mount Sinai

Jump to Overview ↓

“The prognosis for mesothelioma is not as grim as often portrayed. Many factors affect the journey, ranging from the patients to the options on treatments that patients chose. It’s important for patients to stay positive and to know that long-term survivors do exist.”

Dr. Catherine Perrault,
chief medical officer and board-certified family physician with The Mesothelioma Center’s Medical Outreach Team

Jump to Overview ↓

“Before you begin to fight, you must first arm yourself with the right tools. Get your mind right. It’s extremely hard to develop a positive attitude when possibly facing death, but it’s possible. I decided that although the statistics were horrible, I was going to be the exception.”

Kasie C.,
peritoneal mesothelioma survivor

Jump to Overview ↓

Expert Take

Dr. Andrea Wolf: What Is the Prognosis for Mesothelioma Patients?

Prognosis for mesothelioma is dependent on the patient and when it is diagnosed. Thoracic surgeon Dr. Andrea Wolf discusses what prognosis looks like for mesothelioma patients.

1:12

The prognosis for mesothelioma patients is not as good as it is with some other cancers that you hear about, such as breast or prostate cancer in most cases, but it is not nearly as bad as is often portrayed. And so what I try to convey to patients is a lot of this is based on all comers. And many patients with mesothelioma present or come to attention and are diagnosed very late in the game.

Especially in people who are diagnosed earlier, people with early-stage disease, and certain types and certain factors that contribute to that prognosis are very individual. And how any one person does is very specific to that person, not some large data set. So while it's a difficult and challenging disease, the prognosis is variable. And people need to stay positive in order to become those patients who live long term because we have those.

Overview
By Type
By Stage
Other Factors
Chances of Recovery
Improving Prognosis
FAQs

Overview

What Is the Prognosis for Mesothelioma?

While the prognosis for mesothelioma is serious, no two mesothelioma patients are the same. Many factors determine a person’s outlook, including cancer type, stage at diagnosis, treatment choices and overall health. Survival varies widely based on those factors.

Mesothelioma Prognosis at a Glance

About 15% of patients live 5 years or longer.
Epithelioid cell type, early-stage diagnosis and being under 50 are factors associated with more favorable outcomes.
Surgery eligibility improves outcomes, but only about 20% of patients qualify.
New treatments approved in 2024 and 2025 offer hope.

Treatment significantly changes outcomes for people with mesothelioma. With treatment, most people with mesothelioma live 1 to 2 years after receiving their diagnosis. Without it, life expectancy drops to 6 to 8 months. Treatment advances, including new immunotherapy drugs like Keytruda (pembrolizumab) combined with chemotherapy, have improved survival rates. Early diagnosis and aggressive care often lead to a better prognosis.

Mesothelioma Prognosis: With Treatment vs. Without Treatment

Situation	Typical Survival	Notes
With treatment (all types)	12 to 24 months	Multimodal therapy improves outcomes
Without treatment	6 to 8 months	Palliative care can manage symptoms
With treatment — peritoneal, surgery + HIPEC eligible	4 to 5 years	Highest survival rates of all mesothelioma types
With treatment — pleural, early stage	2+ years	Stage 1 and 2 patients who undergo lung-sparing surgery

By Type

Mesothelioma Prognosis by Type

Peritoneal and testicular mesothelioma generally offer the most favorable prognosis, while pleural and pericardial tend to have poorer outlooks. Treatment access, particularly surgery eligibility, drives most of these differences. The Centers for Disease Control and Prevention notes that tumor origin defines the type of mesothelioma a person has.

Kasie C., diagnosed with peritoneal mesothelioma in 2010, tells us her cancer went into remission in 2012. She underwent several cycles of chemotherapy and HIPEC treatments.

Survivor Experience

“Before you begin to fight, you must first arm yourself with the right tools. Get your mind right. It’s extremely hard to develop a positive attitude when possibly facing death, but it’s possible. I decided that although the statistics were horrible, I was going to be the exception.”

Kasie C. , peritoneal mesothelioma survivor

Verified Asbestos.com Survivor

Pleural Mesothelioma Prognosis

Pleural mesothelioma is the most common type, forming in the lining of the lungs. Only about 20% of people with pleural mesothelioma qualify for surgery, which is the single biggest contributing factor to its less favorable outcomes compared to other types. About 12% of people with pleural mesothelioma live 5 years or more, but those with an early-stage diagnosis who undergo aggressive, lung-sparing surgery often live 2 years or longer.

A 2022 study in the journal Cancers reported patients with stage 1 or 2 pleural mesothelioma had a median survival of 32.1 months. Early detection combined with multimodal treatment, including surgery, chemo and immunotherapy, is key in improving outcomes.

Pleural vs Peritoneal Mesothelioma Prognosis

Type	Average Survival	5-Year Survival Rate
Pleural Mesothelioma	12 to 18 months	Around 12%
Peritoneal Mesothelioma	4 to 5 years	47 to 52%

Peritoneal Mesothelioma Prognosis

Peritoneal mesothelioma has the most favorable prognosis of all types because it responds exceptionally well to tumor-removing surgery paired with heated intraperitoneal chemotherapy. About 47% to 52% of patients who receive surgery with HIPEC survive at least 5 years after diagnosis.

HIPEC helps control the cancer better than other treatments alone. People with peritoneal mesothelioma often experience longer survival and better quality of life when they receive care at specialized centers. Survivor Tamron Little has lived more than 18 years since her diagnosis and aggressive surgery. She now advocates for patients facing similar diagnoses.

What Tamron Little Wished She Had Known When Receiving a Mesothelioma Diagnosis

Survivor Story

Tamron Little: What I Wish I Knew When I Received My Mesothelioma Diagnosis

Peritoneal mesothelioma survivor Tamron Little shares what she wished she had known after receiving a mesothelioma cancer diagnosis.

0:40

One thing that I wish I would have known when I was diagnosed that I know now is that you can survive and have a thriving life after mesothelioma.

All of the things that I was reading was giving me poor prognosis, so I wish I would have known that from the start because I could have handled it better than I did from the beginning.

Pericardial Mesothelioma Prognosis

Pericardial mesothelioma is very rare, affecting the lining around the heart. It has the poorest outlook, with most patients surviving only 2 to 6 months after diagnosis. Treatment options are limited, but chemo or surgery can sometimes extend survival. Few patients live beyond a year, making this the most challenging mesothelioma type. Because of its rarity, detailed prognosis data is limited.

Testicular Mesothelioma Prognosis

Testicular mesothelioma is also rare but tends to have a better outlook than other types. Patients who undergo surgery have a median survival of about 4 years. Around 50% reach the 5-year mark. Some have lived more than 10 years. Surgery often successfully controls this cancer type when caught early.

Surviving Mesothelioma Book

A Survivor’s Guide to Living With Mesothelioma

Learn about Judy Glezinski’s inspiring journey as a mesothelioma survivor, and get tips on how to improve your prognosis.

Get Your Free Book

By Stage

Mesothelioma Prognosis by Stage (1–4)

Staging is one of the most critical factors in mesothelioma prognosis. Generally, the earlier the stage at diagnosis, the better the outlook. Early-stage diagnosis combined with aggressive, lung-sparing surgery leads to these better outcomes. While the prognosis for stage 4 is poorest, some stage 4 patients defy odds and live longer with palliative care and targeted treatments.

It’s important to remember every patient is different, and outcomes can vary widely. People with advanced stage mesothelioma may live longer with successful treatment. Seeking expert care can ensure you receive personalized care optimized for you, potentially extending survival and improving quality of life.

Mesothelioma Prognosis by Stage

Stage	Life Expectancy	2-Year Survival	5-Year Survival	Surgery Eligibility
Stage 1	19 to 22 months	About 39%	About 22.5%	Most patients qualify; cancer is still localized
Stage 2	About 19 months	About 38%	About 11%	Some patients qualify with multimodal therapy
Stage 3	About 16 months	About 34%	About 16%	Less likely to qualify as cancer spreads further
Stage 4	13 to 15 months	About 25%	About 7%	Rarely qualify even with multimodal therapy

Exclusive Content

Sean Marchese, RN: How will personalized treatment help a mesothelioma patient’s prognosis?

By making treatment options more personalized to a specific patient’s type of cancer, where the cancer is, how they’ve responded to treatment in the past. It means that doctors can go in and look and see what potential avenues they can explore that haven’t been explored before. It improves the prognosis of these patients because now there are options that they know will have a better chance of success before trying other types and failing.

Other Factors

Other Factors That Affect Mesothelioma Prognosis

In addition to stage and mesothelioma type, other factors affecting mesothelioma prognosis include age, gender and overall health. Younger people and women tend to have better outcomes. Those with co-existing health conditions or otherwise poor health tend to have poorer outlooks.

While you can’t control factors like your tumor cell type, you can improve your personal prognosis with mesothelioma treatment. Pleural mesothelioma survivor Michael Cole shares his firsthand experience of treatment, sharing, “I believe that the aggressive treatment I had in the beginning was absolutely necessary to give me a chance to be here now. And I am grateful for the decision that we made.”

Expert Insight

I’ve treated many mesothelioma patients over the years, and the treatments for it can be tough. Many times, aggressive treatment is necessary to extend their lives and improve their quality of life.

Dr. Jacques Fontaine , board-certified thoracic surgeon

Factors That Affect Mesothelioma Prognosis

Factor	Generally Favorable	Often Less Favorable	What to Know
Tumor location	Peritoneal or testicular	Pleural or pericardial	Peritoneal mesothelioma has the highest survival rates and responds well to surgery combined with HIPEC. Pericardial is the rarest and most difficult to treat early.
Stage	1 or 2	3 or 4	Earlier-stage disease offers more treatment options, including surgery. But patients at every stage have options, and some later-stage patients respond well to immunotherapy or clinical trials.
Cell type	Epithelioid	Sarcomatoid or biphasic	Epithelioid cells respond best to treatment. Biphasic tumors contain a mix of cell types, so outcomes vary depending on the ratio.
Age	Under 50	75 or older	Younger patients are more likely to tolerate aggressive treatment. But age alone doesn’t determine eligibility. Doctors weigh overall health and fitness for surgery more than age.
Gender	Women	Men	Women tend to live longer with mesothelioma, particularly with peritoneal disease. Researchers are still studying why this difference exists.
Overall health	Active, no chronic illness	Significant coexisting conditions	Patients in good general health can usually access a wider range of treatments. Chronic conditions like heart disease or reduced lung function can affect which options are on the table.
Treatment	Multimodal therapy	No treatment or palliative care only	Combining surgery, chemotherapy, immunotherapy and/or radiation tends to produce the best outcomes. Palliative care alone focuses on quality of life and comfort rather than extending survival.

Cell Type

Cell type is one of the strongest predictors of how mesothelioma responds to treatment. There are 3 mesothelioma cell types, each with meaningfully different outlooks. The third type is a combination of the others. Among the three mesothelioma cell types, epithelioid offers the most favorable prognosis, sarcomatoid is associated with the poorest outcomes, and biphasic outcomes vary depending on which cell type predominates.

Mesothelioma Cell Types Can Affect Prognosis

Epithelioid: This is the most common cell type and it responds best to treatment. People with epithelioid tumors tend to live longer because these cells grow more slowly and stay localized longer.
Sarcomatoid: This type grows quickly and spreads early. It often responds poorly to standard treatment, though immunotherapy is helping improve prognoses.
Biphasic: This type is a mix of epithelioid and sarcomatoid cells. Outcomes often vary depending on which cell type outnumbers the other.

Knowing your mesothelioma cell type helps your doctor select the most effective treatment plan for you. This information helps your doctor better understand the complex combination of factors that may influence your outlook.

Patient and Demographic Factors

Certain patient characteristics can also affect how well someone with mesothelioma may respond to treatment. These factors can influence overall prognosis and survival.

Important Factors That Can Influence Prognosis and Survival

Age: Patients under 50 often have better outcomes as they’re more likely to qualify for and tolerate aggressive treatments.
Gender: Women tend to live longer than men with mesothelioma, though researchers are still studying the reasons for this difference.
Overall health: People with active lifestyles and no chronic illnesses tend to tolerate treatment better.
Race: Black patients show a higher 5-year survival rate (21.3%) compared to white patients (13.9%) in some studies, according to SEER.

Statistics offer broad patterns, but individual outcomes often surprise doctors. Susan D. proved that persistence and the right mesothelioma surgeon could overcome both her age and advanced diagnosis. Diagnosed at 72 with stage 4 peritoneal mesothelioma, Susan was initially told she wasn’t a surgery candidate, but she refused to accept palliative care as her only option. More than a decade since her tumor-removing surgery, Susan says she hasn’t had a recurrence and “Life is good.”

Free Webinar

Mesothelioma Clinical Trials 101

Join Dr. Catherine Perrault for a free webinar to learn how clinical trials work, who qualifies and how to find one that fits your diagnosis.

Get Your Free Recording

Chances of Recovery

Can Mesothelioma Go Into Remission?

While there is no cure for mesothelioma, remission does happen. In our 2025 survey, 11% of patients who told us their doctor said they’re in remission or cancer-free. All of those in remission had received treatment including surgery (23%) and a combination of chemo and surgery (76%).

Mesothelioma type also affected remission rates. Of patients with peritoneal mesothelioma, 16% reported remission compared to 8% of those with pleural mesothelioma.

Mesothelioma Patients Reported Remission

11%

Source: The Mesothelioma Center’s 2025 Patient Survey

Patients in Remission had Treatment

100%

Source: The Mesothelioma Center’s 2025 Patient Survey

These findings show remission is possible with tailored treatment, underscoring the importance of expert mesothelioma care. Every patient’s journey is unique, and thanks to advances in therapies and approaches, there’s hope for those coping with a mesothelioma diagnosis.

Dr. Andrea Wolf, who directs the New York Mesothelioma Program at Mount Sinai, helps many people with mesothelioma improve their prognosis. Dr. Wolf tells us, “I’m realistic. And there is good reason today to be optimistic. We can help these patients. We’ve proven that. They can live with mesothelioma if treated effectively.”

Mesothelioma Caregiver

Kim S: What We Were Told About My Dad’s Mesothelioma Prognosis

Before the surgery, there was just, like, if he did nothing, it was probably gonna be, like, six months maybe if he did nothing, maybe nine at the most.

With having the surgery, then they would have been able to extend it, you know, maybe, like, a year, eighteen months.

And, but, yeah, without doing anything, it would probably only been about six months or so.

Improving Prognosis

How to Improve Your Mesothelioma Prognosis

Seeing a specialist, pursuing multimodal therapy and considering clinical trials are among the most impactful steps a person with mesothelioma can take. Maintaining overall health through diet and exercise can also make a meaningful difference in survival and quality of life.

5 Tips for Improving Your Mesothelioma Prognosis

Ask about multimodal therapy: Multimodal therapy combines surgery, chemo and/or immunotherapy to target cancer in different ways. People often see better results with a combination of treatments.
Consider palliative and supportive care: Palliative care helps people with mesothelioma manage symptoms like pain. Supportive care addresses your physical and mental health needs from side effect management to support groups and counseling.
Find a mesothelioma specialist: A mesothelioma specialist has experience treating this rare cancer and can offer access to clinical trials, newer therapies and specialized surgical techniques that general hospitals don’t provide, all of which can make a real difference in your treatment plan and outlook.
Make healthier lifestyle choices: Gentle exercise and a balanced diet can help. They can reduce side effects and improve mesothelioma symptoms.
Participate in a clinical trial: Clinical trials offer access to cutting edge therapies that may improve your outlook.

Michael Cole tells us he was very active before his diagnosis, but it was challenging to exercise after surgery. He shares, “Exercise is very important to keeping our strength up and our bodies working correctly. In my experience, it can also be one of the hardest things to do. After my extrapleural pneumonectomy surgery they had me up walking within a very short period of time. It was hard, and I really didn’t want to do it, but they told me if I did not I would die. Not a bad motivator. Since then, my wife has helped motivate me to exercise, even when I do not want to.”

Asbestos.com Expert Takeaway

Expert Takeaways on Mesothelioma Prognosis

Research suggests that heated chemo after pleurectomy decortication surgery may improve overall survival compared to surgery alone.
Average prognosis reflects general statistics. Predicting an individual’s treatment response is difficult. Overall health and lifestyles play a role. Your prognosis is personal.

“The prognosis for mesothelioma is not as grim as often portrayed. Many factors affect the journey, ranging from the patients to the options on treatments that patients chose. It’s important for patients to stay positive and to know that long-term survivors do exist.”

Dr. Catherine Perrault, medical officer and board-certified family physician with The Mesothelioma Center’s Medical Outreach Team

What Patients and Families Say

5 out of 5 stars

The Patient Advocates are absolutely amazing and helpful! I am so very pleased with the information and the emotional support that I have received from everyone! When I felt all hope was lost, Amy gave me great information and was so compassionate. I do not feel alone, and I know there is strong support for anyone dealing with this tragic disease. I received a FREE information package, including a recipe book, information on the disease, a toll-free number to contact for assistance, and a book with the answers to 100 questions that are commonly asked. This information alone was worth my time! I read for hours and hours, and just that alone—knowledge—can be a great comfort. To fully understand this disease, to just have the knowledge!!! Thank you all!! Thank you so, so much.

Read full review

Pamela K.

Mesothelioma Patient

5 out of 5 stars

I found out about The Mesothelioma Center while researching peritoneal mesothelioma days after being diagnosed with the malignant cancer. While a lot of the 'Mesothelioma' websites are actually law firms just trying to get your business, theirs is a user-friendly, comprehensive website set up to aid patients, their loved ones, and/or caregivers with all things related to a cancer diagnosis from asbestos exposure. I was soon put in touch with one of their doctors, Snehal Smart, M.D., who immediately sent me a packet of general information, a book on surviving mesothelioma, and offered me assistance in finding doctors, reputable law firms, financial help, support groups, and so much more! The Mesothelioma Center's website is, in my opinion, the best resource for anyone suffering from cancer due to asbestos. Dr. Smart is amazing! She is very knowledgeable and helpful, but she is also a very kind, caring doctor who goes the distance whether she is researching a pertinent topic, making suggestions, providing contacts, or just being a good listener on the other end of the phone. In addition, Dr. Smart referred me to a law firm who is now fighting to get me compensation for the negligence of those defendants whose products exposed me to asbestos and caused my subsequent cancer. Thank you, TMC and Dr. Smart, for helping me determine the best treatment plan for my cancer and being part of my miracle. I am currently cancer-free and back to being a mom to my precious daughter. The Mesothelioma Center, their website, and their staff rock!!

Read full review

Karen F.

Mesothelioma Patient

5 out of 5 stars

I reached out and talked to Aaron a couple of weeks before my diagnosis of malignant mesothelioma. He was very helpful and gave me a lot of information at that time. I have talked to him several times since and always gotten my questions answered. Aaron is very knowledgeable and has been very helpful and supportive. He also sent me a comprehensive packet of information, including info on nutrition, legal help, and medical resources.

Read full review

Stan B.

Mesothelioma Patient

5 out of 5 stars

My brother was recently diagnosed with mesothelioma. I began researching it online. The information I received from The Mesothelioma Center is all-inclusive. No need to look anywhere else! The first phone call was with Karen, and she answered all my questions with ease. She also had a calming effect by presenting all the options available for my brother and his family. Thank you!

Read full review

Cindy W.

Sister of a Mesothelioma Patient

5 out of 5 stars

My Dad was diagnosed with mesothelioma, and thankfully The Mesothelioma Center was the first place I called. Snehal Smart answered the phone immediately and was very helpful. She immediately sent us an information packet and answered questions. She followed up each week to see how things were going and if we had any questions. She also connected us with a lawyer. I highly recommend this Center.

Read full review

Patrick K.

Son of a Mesothelioma Patient

All Testimonials

A Patient Advocate meeting with a couple

Explore Next Steps

You Don’t Have to Face a Diagnosis Alone

Patient Advocates can help you understand your treatment options, prepare questions, find specialists and connect with resources that may be right for you.

Speak With a Patient Advocate or Call (855) 404-4592

FAQs

Common Questions About Mesothelioma Prognosis

We asked The Mesothelioma Center’s team of Patient Advocates what patients ask about mesothelioma prognosis when they call us. They’ve shared these questions along with their helpful answers.

Most people with mesothelioma live 12 to 24 months with treatment. Without treatment, survival often is measured in months, usually 6 to 8. Some patients live for many years, even more than a decade, especially when working with experienced mesothelioma specialists.

About 15% of all mesothelioma patients are alive 5 years after diagnosis, but the figure varies sharply by type and stage. By stage, 5-year survival is about 22.5% for stage 1, 11% for stage 2, 16% for stage 3 and 7% for stage 4. About 47% to 52% of peritoneal mesothelioma patients who receive surgery with HIPEC survive at least 5 years after diagnosis. Cell type, age and overall health also influence individual outcomes.

Mesothelioma can return after treatment. The cancer may be controlled but not completely cured. Regular follow-ups are essential to catch any signs of mesothelioma recurrence early.

Mesothelioma specialists have experience treating this rare cancer. They can offer the latest therapies, tailor care plans to your needs, and help you access clinical trials. Working with a specialist often improves both prognosis and quality of life.

Mesothelioma prognosis is a doctor’s broader clinical assessment of how a person’s cancer will likely progress, covering treatment response, quality of life and overall disease course. Life expectancy refers specifically to survival duration in months or years. Prognosis informs life expectancy estimates but encompasses more than survival time alone.

Several factors contribute to a more favorable mesothelioma prognosis, including an early-stage diagnosis (Stage 1 or 2), epithelioid cell type, peritoneal tumor location, being a woman, younger age at diagnosis and good overall health. Choosing treatment, particularly multimodal therapy, also significantly improves outcomes. Patients can’t control all of these factors, but treatment decisions can make a meaningful difference.

Share This Article:

This Page Contains 8 Cited Articles

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

CDC. (2025, February 13). Incidence of Malignant Mesothelioma. Retrieved from https://www.cdc.gov/united-states-cancer-statistics/publications/mesothelioma.html
Zhu, W., Liu, J., Li, Y. et al. (2023). Global, regional, and national trends in mesothelioma burden from 1990 to 2019 and the predictions for the next two decades. Retrieved from https://doi.org/10.1016/j.ssmph.2023.101441
Holzknecht, A. et al. (2022, April 30). Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC9104590/
National Cancer Institute. (2021, May 21). Malignant mesothelioma Treatment (Adult) (PDQ) – Patient Version. Retrieved from https://www.cancer.gov/types/mesothelioma/patient/mesothelioma-treatment-pdq
Carosio, R., Fontana, V., Mastracci, L. et al. (2021). Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis. Retrieved from https://link.springer.com/article/10.1007/s00432-020-03457-7
National Cancer Institute. (2021). Mesothelioma SEER 5-Year Relative Survival Rates, 2015-2021. Retrieved from https://seer.cancer.gov/statistics-network/explorer/application.html
National Cancer Institute. (2020). Mesothelioma Recent Trends in SEER Relative Survival Rates, 2000-2020. Retrieved from https://seer.cancer.gov/statistics-network/explorer/application.html
Ohara, Y., Enomoto, A., Tsuyuki, Y. et al. (2020). Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma. Retrieved from https://www.spandidos-publications.com/10.3892/or.2020.7669

Current Version
March 13, 2026

Written By
Daniel Landau
Edited By
Amy Edel
Medically Reviewed By
Jacques Fontaine
November 6, 2025

Written By
Daniel Landau
Edited By
Amy Edel
Medically Reviewed By
Jacques Fontaine
September 25, 2025

Written By
Daniel Landau
Edited By
Amy Edel
Medically Reviewed By
Jacques Fontaine
June 9, 2025

Written By
Daniel Landau
Edited By
Amy Edel
Medically Reviewed By
Jacques Fontaine
June 6, 2025

Written By
Daniel Landau
Edited By
Walter Pacheco
Medically Reviewed By
Jacques Fontaine

Why Trust Asbestos.com?

Written By:

Karen Selby

Registered Nurse and Board Certified Patient Advocate | (855) 404-4592 | karen@asbestos.com

Karen Selby is a registered nurse and Board Certified Patient Advocate at The Mesothelioma Center with more than 30 years of experience in oncology and thoracic surgery. She worked as an operating room nurse in thoracic surgery at the University of Maryland for 6 years, assisting with surgeries such as lung transplants, pneumonectomies and pleurectomies. She later served as regional director of the tissue procurement program at the University of Florida. Karen joined The Mesothelioma Center in 2009, providing patients with personalized support and resources.

Expertise in mesothelioma, cancer therapy and immunotherapy
Board-Certified Patient Advocate and Licensed Registered Nurse (1991)
MBA, University of Central Florida (1999)
BSN, University of South Alabama (1996)
Member, Academy of Oncology Nurse & Patient Navigators
Founded and launched The Mesothelioma Center's Community Outreach Program (2022)

Expertise in mesothelioma, cancer therapy and immunotherapy
Board-Certified Patient Advocate and Licensed Registered Nurse (1991)
MBA, University of Central Florida (1999)
BSN, University of South Alabama (1996)
Member, Academy of Oncology Nurse & Patient Navigators
Founded and launched The Mesothelioma Center's Community Outreach Program (2022)

Edited By: